Synthesis and antimycobacterial activity of symmetric thiocarbohydrazone derivatives against mycobacterium bovis BCG

Iranian Journal of Pharmaceutical Research

Volumn 12, Issue 2, 2013, Pages 331-346

  Ebrahim Tehrani, Kamaleddin Haj Mohammad ^a   Kobarfard, Farzad ^a,b   Azerang, Parisa ^c   Mehravar, Maryam ^c   Soleimani, Zohreh ^a   Ghavami, Ghazaleh ^c   Sardari, Soroush ^c  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c PASTEUR INSTITUTE OF IRAN   (Iran)

Author keywords

Antifungal; In silico; Mycobacterium bovis; Thiacetazone; Thiocarbohydrazone

Indexed keywords

BCG VACCINE; BIS(2 ACETYLPYRIDINE) THIOCARBOHYDRAZONE; BIS(2 BROMOBENZALDEHYDE) THIOCARBOHYDRAZONE; BIS(2 CHLOROBENZALDEHYDE) THIOCARBOHYDRAZONE; BIS(2 FLUOROBENZALDEHYDE) THIOCARBOHYDRAZONE; BIS(2 NITROBENZALDEHYDE) THIOCARBOHYDRAZONE; BIS(3 BROMOBENZALDEHYDE) THIOCARBOHYDRAZONE; BIS(3 CHLOROBENZALDEHYDE) THIOCARBOHYDRAZONE; BIS(3 FLUOROBENZALDEHYDE) THIOCARBOHYDRAZONE; BIS(3 NITROBENZALDEHYDE) THIOCARBOHYDRAZONE; BIS(4 ACETAMIDOBENZALDEHYDE) THIOCARBOHYDRAZONE; BIS(4 ACETYLPYRIDINE) THIOCARBOHYDRAZONE; BIS(4 BROMOACETOPHENONE) THIOCARBOHYDRAZONE; BIS(4 BROMOBENZALDEHYDE) THIOCARBOHYDRAZONE; BIS(4 CHLOROBENZALDEHYDE) THIOCARBOHYDRAZONE; BIS(4 FLUOROACETOPHENONE) THIOCARBOHYDRAZONE; BIS(4 FLUOROBENZALDEHYDE) THIOCARBOHYDRAZONE; BIS(4 NITROBENZALDEHYDE) THIOCARBOHYDRAZONE; BIS(4CLOROACETOPHENONE) THIOCARBOHYDRAZONE; BIS(ACETOPHENONE) THIOCARBOHYDRAZONE; BIS(BENZALDEHYDE) THIOCARBOHYDRAZONE; BIS(FURAN 2 CARBALDEHYDE) THIOCARBOHYDRAZONE; BIS(N (4 ACETYLPHENYL) ACETAMIDE) THIOCARBOHYDRAZONE; BIS(PYRIDINE 2 CARBALDEHYDE) THIOCARBOHYDRAZONE; BIS(PYRIDINE 3 CARBALDEHYDE) THIOCARBOHYDRAZONE; BIS(PYRIDINE 4 CARBALDEHYDE) THIOCARBOHYDRAZONE; BIS(THIOPHENE 2 CARBALDEHYDE) THIOCARBOHYDRAZONE; ETHAMBUTOL; HYDRAZONE DERIVATIVE; THIOCARBOHYDRAZONE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ARTEMIA; ARTICLE; BIOLOGICAL ACTIVITY; CANDIDA ALBICANS; DRUG SYNTHESIS; MASS SPECTROMETRY; MYCOBACTERIUM BOVIS; NONHUMAN; TUBERCULOSIS;

EID: 84878899647     PISSN: 17350328     EISSN: 17266890     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. World Health Organization. Global tuberculosis control: epidemiology, strategy, financing. WHO report (2009). Available online at: http://www.who.int/tb/publications/global_report/2009/en/index.html.
2. Dorman SE and Chaisson RE, From magic bullets back to the magic mountain: the rise of extensively drug resistant tuberculosis, Nat. Med. (2007) 13: 295-298.
3. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep. (2006) 55: 301-305.
4. Kobarfard F, Tuberculosis and traditional medicine: fighting the oldest infectious disease using the oldest source of medicines, Iranian J. Pharm. Res. (2004) 2: 71-72.
5. Davidson PT and Le HQ, Drug treatment of tuberculosis, Drugs (1992) 43: 651-673.
6. Bermudez LE, Reynolds R, Kolonoski P, Aralar P, Inderlied CB and Young LS, Thiosemicarbazole (thiacetazone-like) compound with activity against Mycobacterium avium in mice, Antimicrob. Agents. Chemother. (2003) 47: 2685-2687.
7. Kobarfard F and Kauffman JM, Halogenated antituberculosis agents. United States patent (2003) US2003114531.
8. Dover LG, Alahari A, Gratraud P, Gomes JM, and Bhowruth V. E., Eth A, a common activator of thiocarbamide-containing drugs acting on different mycobacterial targets, Antimicrob. Agents. Chemother. (2007) 51: 1055-1063.
9. Qian L and Ortiz de Montellano PR, Oxidative activation of thiacetazone by the Mycobacterium tuberculosis flavin monooxygenase EtaA and human FMO1 and FMO3. Chem. Res. Toxicol. (2006) 19: 443-449.
10. DeBarber AE, Mdluli K, Bosman M, Bekker LG and Barry CE, Ethionamide activation and sensitivity in multidrug resistant Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA (2000) 97: 9677-9682.
11. Sardari S, Shaghaghi B, and Borna H. in Mendez-Vilas, A. Ed, Microorganisms in Industry and Environment, from scientific and industrial research to consumer products. World Scientific, New Jersey, (2011) 665.
12. Camacho-Corona M R, Ramirez-Cabrera MA, Santiago OG, Garza-Gonzalez E, Palacios Idel P and Luna Herrera J, Activity against drug resistant-tuberculosis strains of plants used in Mexican traditional medicine to treat tuberculosis and other respiratory diseases. Phytother. Res. (2008) 22: 82-85.
13. Cuenca-Estrella M, Lee-Yang W, Ciblak MA, Arthington-Skaggs BA, Mellado E and Warnock DW, Comparative evaluation of NCCLS M27-A and EUCAST broth microdilution procedures for antifungal susceptibility testing of Candida species. Antimicrob. Agents. Chemother. (2002) 51: 3644-3647.
14. Borowitz JL and McLaughlin JL, Evidence for Calcium Channels in Brine Shrimp: Oiltlazem Protects Shrimp against Cadmium, Bull. Environ. Contam. Toxicol. (1992) 48:435-440.
15. Hartl M and Humpf HU, Toxicity assessment of fumonisins using the brine shrimp (Artemia salina) bioassay, Food. Chem. Toxicol. (2000) 38: 1097-1102.
16. Favilla M, Macchia L, Gallo A and Altomare C, Toxicity assessment of metabolites of fungal biocontrol agents using two different (Artemia salina and Daphnia magna) invertebrate bioassays, Food. Chem. Toxicol. (2006) 44: 1922-1931.
17. Baravalia Y, Vaghasiya Y and Chanda S, Brine Shrimp cytotoxicity, anti-inflammatory and analgesic properties of Woodfordia fruticosa Kurz Flowers. Iranian J. Pharm. Res. (2012) 11: 851-861.
18. Burns GR, Metal complexes of thiocarbohydrazide, Inorg. Chem. (1968) 7: 277-283.
19. Richardson DR, Kalinowski DS, Richardson V, Sharpe PC, Lovejoy DB, Islam M and Bernhardt PV. 2-Acetylpyridine thiosemicarbazones are potent iron chelators and antiproliferative agents: redox activity, iron complexation and characterization of their antitumor activity. J. Med. Chem. (2009) 52: 1459-1470.
20. Kalinowski DS, Yu Y, Sharpe PC, Islam M, Liao Y, Lovejoy DB, Kumar N, Bernhardt PV and Richardson DR. Design, synthesis, and characterization of novel iron chelators: structure activity relationships of the 2-benzoylpyridine thiosemicarbazone series and their 3-nitrobenzoyl analogues as potent antitumor agents. J. Med. Chem. (2007) 50: 3716-3729.
21. Barry CE, Slayden RA, Sampson AE and Lee RE. Use of genomics and combinatorial chemistry in the development of new antimycobacterial drugs. Biochem. Pharmacol. (2000) 59: 221-231.
22. Morrison NE and Collins FM. Antimycobacterial activity of 2-acetylpyridine thiosemicarbazones in relation to their antileprosy activity. Int. J. Lepr. (1981) 49:180-186.
23. Bartzatt R, Cirillo SLG and Cirillo JD. Determination of the molecular properties effectuating the growth inhibition of Mycobacterium tuberculosis by various small molecule hydrazides. Lett. Drug. Des. Disc. (2008) 5: 162-168.
24. Baulard AR., Betts JC, Engohang-Ndong J, Quan S, McAdam RA, Brennan PJ, Locht C and Besra GS. Activation of the pro-drug ethionamide is regulated in mycobacteria. J. Biol. Chem. (2000) 275: 28326-28331.
25. Alahari A, Trivelli X, Guerardel Y, Dover LG, Besra GS, Sachhettini JC, Reynolds RC, Coxon GD and Kremer L. Thiacetazone, an antitubercular drug that inhibits cyclopropanation of cell wall mycolic acids in mycobacteria. Plos one (2007) 2: e1343.
26. Ferrão-Filho SA and Kozlowsky-Suzuki B. Cyanotoxins: Bioaccumulation and Effects on Aquatic Animals. Mar. Drugs (2011) 9: 2729-2772.